TY -的T1 -协会呼吸困难,死亡率、住院病人和资源使用摩根富林明-欧洲呼吸杂志》乔和J - 10.1183/13993003.02107 -2019欧元SP - 1902107 AU -史蒂文斯,詹妮弗·p·盟——Dechen丹增AU - Schwartzstein,理查德。m . AU - O ' donnell卡尔AU -贝克,凯西盟——Banzett罗伯特b . Y1 - 2021/01/01 UR - //www.qdcxjkg.com/content/early/2021/01/21/13993003.02107 - 2019. -抽象N2 -多达10个病人经历呼吸困难在住院病人呼吸困难和结果之间的关系是未知。我们试图确定呼吸困难入院时预测的结果。我们进行了一项回顾性队列研究在单一,学术医疗中心。我们分析了67年362年连续住院和可用数据呼吸困难,痛苦,和结果。作为初始的一部分病人评估护士、患者评为“呼吸不适”使用0到10,(10 =“无法忍受”)。病人呼吸困难的时候入学报道,回忆在入学前24小时呼吸困难经验。结果包括住院死亡率,2年死亡率、住院时间,需要快速反应系统激活,转移到重症监护室,放电扩展护理,7 - 30天的所有导致重新接纳相同的机构。报告任何呼吸困难的病人在住院期间死亡的风险增加;呼吸困难越大,越大的死亡风险(呼吸困难= 0,住院死亡率0.8%;呼吸困难= 1 - 3,死亡率2.5%;呼吸困难≥4,死亡率3.7%,术中;0.001)。 After adjustment for patient comorbidities, demographics, and severity of illness, increasing dyspnea remained associated with inpatient mortality (dyspnea 1–3, aOR 2.1, 95% CI 1.7–2.6; dyspnea ≥4, aOR 3.1, 95% CI 2.4–3.9). Pain did not predict increased mortality. Patients reporting dyspnea also used more hospital resources, were more likely to be readmitted, and were at increased risk of death within 2 years (dyspnea=1–3 adjusted HR 1.5, 95% CI 1.3–1.6; dyspnea ≥4 adjusted HR 1.7, 95% CI 1.5–1.8).We found that dyspnea of any rating was associated with an increased risk of death. Dyspnea can be rapidly collected by nursing staff, which may allow for better monitoring or interventions that could reduce mortality and morbidity.FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Stevens reports grants from NIH/NINR, during the conduct of the study; other from McGraw-Hill, other from Up-To-Date, outside the submitted work.Conflict of interest: Dr. Dechen has nothing to disclose.Conflict of interest: Dr. Schwartzstein has nothing to disclose.Conflict of interest: Dr. O'Donnell has nothing to disclose.Conflict of interest: Dr. Baker has nothing to disclose.Conflict of interest: Dr. Banzett reports grant NR010006 from NIH/NINR, during the conduct of the study. ER -